Why the study?
Does losartan improve cardiac mitochondrial dysfunction and phenotypic changes in mouse models of aging and inflammation?
Population
Male C57BL/6J wild-type (WT) and IL-10 knockout (IL-10−/−) mice, young (4–6 months) and aged (22–24 months)
Comparison
Losartan ad libitum in drinking water for 4 weeks vs Placebo (untreated) age- and genotype-matched mice
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Losartan effects on cardiac remodeling merit human trials in inflammatory cardiomyopathy; leaves open mitochondrial benefits and clinical translation.
Does losartan improve cardiac mitochondrial dysfunction and phenotypic changes in mouse models of aging and inflammation?
In a mouse model, the combination of aging and inflammation causes distinct molecular changes in the cardiac renin-angiotensin system that lead to cardiomyopathy, which can be partially reversed by AT1R blockade with losartan.
Burks et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: